Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation
Authors
Keywords
Biomarkers, Smoking habits, Urine, Creatinine, Oxidative damage, Inflammation, Inflammatory diseases, Metabolites
Journal
PLoS One
Volume 14, Issue 4, Pages e0215853
Publisher
Public Library of Science (PLoS)
Online
2019-04-26
DOI
10.1371/journal.pone.0215853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship of the oxidative damage biomarker 8-epi-prostaglandin F2α to risk of lung cancer development in the Shanghai Cohort Study
- (2018) Jian-Min Yuan et al. CARCINOGENESIS
- Analysis of Urinary Eicosanoids by LC–MS/MS Reveals Alterations in the Metabolic Profile after Smoking Cessation
- (2018) Michael Goettel et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Role of ROS and Nutritional Antioxidants in Human Diseases
- (2018) Zewen Liu et al. Frontiers in Physiology
- Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure
- (2018) Dorothy K. Hatsukami et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop
- (2017) Cindy M Chang et al. NICOTINE & TOBACCO RESEARCH
- Isoprostanes, neuroprostanes and phytoprostanes: An overview of 25 years of research in chemistry and biology
- (2017) Jean-Marie Galano et al. PROGRESS IN LIPID RESEARCH
- Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease RiskHighlights
- (2016) Cecile C. King et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF2α/PGF2α ratio distinguishes chemical from enzymatic lipid peroxidation
- (2015) Thomas J. van ‘t Erve et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups
- (2014) Sharon E. Murphy et al. CARCINOGENESIS
- Effect of Zileuton and Celecoxib on Urinary LTE4 and PGE-M Levels in Smokers
- (2013) A. Mohebati et al. Cancer Prevention Research
- Urinary PGE-M: A Promising Cancer Biomarker
- (2013) D. Wang et al. Cancer Prevention Research
- Significant Increase of Prostaglandin E-Major Urinary Metabolite in Male Smokers: A Screening Study of Age and Gender Differences Using a Simple Radioimmunoassay
- (2013) Isao Okayasu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Relationship between Biomarkers of Cigarette Smoke Exposure and Biomarkers of Inflammation, Oxidative Stress, and Platelet Activation in Adult Cigarette Smokers
- (2011) J. Liu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Biomarkers of Potential Harm Among Adult Smokers and Nonsmokers in the Total Exposure Study
- (2011) K. Frost-Pineda et al. NICOTINE & TOBACCO RESEARCH
- Intra-Person Variation of Urinary Biomarkers of Oxidative Stress and Inflammation
- (2010) X. Wu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients
- (2009) V. D. Kekatpure et al. Cancer Prevention Research
- Effects of Smoking Cessation on Eight Urinary Tobacco Carcinogen and Toxicant Biomarkers
- (2009) Steven G. Carmella et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Liquid chromatography–tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E2 in human urine
- (2008) Jason R. Neale et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Women and Smokers Have Elevated Urinary F2-Isoprostane Metabolites: A Novel Extraction and LC–MS Methodology
- (2008) Alan W. Taylor et al. LIPIDS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started